Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerestar was a global leader in the production of starch and starch derivatives, serving as a critical supplier to the pharmaceutical, food, and industrial sectors. The company specialized in the manufacture of pharmaceutical-grade excipients, including starches, polyols such as mannitol and sorbitol, and cyclodextrins used to enhance drug solubility and stability. In 2002, Cerestar was acquired by Cargill for approximately $1.1 billion, leading to its integration into Cargill's food and pharma ingredients business. Today, its legacy continues through Cargill's extensive portfolio of life science excipients and nutritional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerestar Holding.